GLP-1 and your kidneys: protection plus a dehydration warning
GLP-1 medicines like semaglutide and liraglutide have shown real kidney-protective effects in people with type 2 diabetes, lowering the risk of kidney failure and worsening kidney disease in major trials. At the same time, the medicine labels warn that severe vomiting or diarrhoea from these drugs can cause dehydration and, in some cases, acute kidney injury, especially in people who already have kidney disease. The honest picture is both: long-term kidney protection in diabetes, plus a real dehydration risk you can lower by drinking fluids and reporting severe gut side effects early.
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.